⠀
📊 𝐑𝐞𝐬𝐮𝐥𝐭𝐬
• Revenue: $267.8M, +73% YoY.
• GAAP EPS: -$0.12 (vs. -$0.03 YoY).
• GAAP Net Loss: $79.7M (vs. $18.3M loss YoY).
• GAAP Operating Loss: $79.2M (vs. $59.0M loss YoY).
• GAAP Gross Profit: $90.1M (vs. $57.3M YoY).
• Operating Cash Flow: +$7.2M.
• Cash & Equivalents: $4.45B.
• Total Backlog: ~$3.6B, +52% QoQ.
⠀
🎯 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞
• Q4 Revenue: $270M–$290M, midpoint $280M.
• Q4 GAAP Gross Margin: 34%–36%.
• Q4 Non-GAAP Gross Margin: 39%–41%.
• Q4 Adjusted EBITDA Loss: $14M–$20M.
• Q4 GAAP Operating Expenses: $162M–$168M.
• Neutron First Launch: No earlier than 2027.
⠀
📌 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬
• Record revenue increased 73% YoY and ~$34M sequentially.
• Backlog surged 52% QoQ to approximately $3.6B.
• Signed nearly $1B in new launch contracts during Q3, bringing launch backlog to a record 117 missions.
• Secured >$515M in Neutron launch contracts, bringing its backlog to 16 missions before its debut.
• Neutron launch pricing increased to $70M for several contracted missions amid tightening industry capacity.
• Neutron's first launch is now targeted for no earlier than 2027.
• Signed $470M in Space Systems contracts during Q3.
• More than 55 spacecraft are currently in development and production.
• Successfully deployed 12 Rocket Lab-built spacecraft, including eight for Globalstar and two Mars science spacecraft for NASA.
• Generated positive GAAP operating cash flow of $7.2M despite a widening net loss.
• Completed equity financing to fully fund the pending Iridium acquisition, with shareholder and lender approvals secured.
• Q4 revenue guidance midpoint implies ~4.5% sequential growth.
⠀
💬 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲
“Q3 2026 was a defining quarter for Rocket Lab. We delivered a record $268 million in revenue ($34 million higher than Q2 2026) alongside a record backlog which has grown to $3.57 billion.”